20
Participants
Start Date
November 15, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
September 30, 2026
intra-arterial tenecteplase administration
Patients will receive a single dose of tenecteplase, administered intra-arterially after successful large vessel recanalization. The treatment will be administered via intra-arterial catheter in the distal M1 segment of the middle cerebral artery (distal to lenticulostriates).
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of Pennsylvania
OTHER